Permira to pay £703m for UK pharma services firm Ergomed
European private equity firm Permira has agreed a deal to acquire British biopharmaceutical services company Ergomed, a provider of clinical research and trial management services, for around £703.1m ($886.40m), according to a report by Reuters.